TY - JOUR
T1 - Electrospun anti-inflammatory patch loaded with essential oils for wound healing
AU - García-Salinas, Sara
AU - Evangelopoulos, Michael
AU - Gámez-Herrera, Enrique
AU - Arruebo, Manuel
AU - Irusta, Silvia
AU - Taraballi, Francesca
AU - Mendoza, Gracia
AU - Tasciotti, Ennio
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/3/15
Y1 - 2020/3/15
N2 - Wound healing is a complex process that consists of three overlapping phases: inflammation, proliferation, and remodeling. A bacterial infection can increase inflammation and delay this process. Microorganisms are closely related to the innate immune system, such as macrophages and neutrophils, as they can start an inflammatory cascade. Essential oils play an important role in the inhibition and prevention of bacterial growth due to their ability to reduce antimicrobial resistance. The possibility to find a strategy that combines antimicrobial and anti-inflammatory properties is particularly appealing for wound healing. In this work, we showcase a variety of patches based on electrospun polycaprolactone (PCL) nanofibers loaded with natural compounds derived from essential oils, such as thymol (THY) and tyrosol (TYR), to achieve reduced inflammation. In addition, we compared the effect these essential oils have on activated macrophages when incorporated into the PCL patch. Specifically, we demonstrate that PCL-THY resulted in more efficient down-regulation of pro-inflammatory genes related to the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κb) pathway when compared to PCL-TYR and the combination patch containing TYR and THY (i.e., PCL-TYR-THY). Furthermore, PCL-THY displayed low affinity for cell attachment, which may hinder wound adherence and integration. Overall, our results indicate that THY-loaded patches could serve as promising candidates for the fabrication of dressings that incorporate bactericidal and anti-inflammatory properties while simultaneously avoiding the limitations of traditional antibiotic-loaded devices.
AB - Wound healing is a complex process that consists of three overlapping phases: inflammation, proliferation, and remodeling. A bacterial infection can increase inflammation and delay this process. Microorganisms are closely related to the innate immune system, such as macrophages and neutrophils, as they can start an inflammatory cascade. Essential oils play an important role in the inhibition and prevention of bacterial growth due to their ability to reduce antimicrobial resistance. The possibility to find a strategy that combines antimicrobial and anti-inflammatory properties is particularly appealing for wound healing. In this work, we showcase a variety of patches based on electrospun polycaprolactone (PCL) nanofibers loaded with natural compounds derived from essential oils, such as thymol (THY) and tyrosol (TYR), to achieve reduced inflammation. In addition, we compared the effect these essential oils have on activated macrophages when incorporated into the PCL patch. Specifically, we demonstrate that PCL-THY resulted in more efficient down-regulation of pro-inflammatory genes related to the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κb) pathway when compared to PCL-TYR and the combination patch containing TYR and THY (i.e., PCL-TYR-THY). Furthermore, PCL-THY displayed low affinity for cell attachment, which may hinder wound adherence and integration. Overall, our results indicate that THY-loaded patches could serve as promising candidates for the fabrication of dressings that incorporate bactericidal and anti-inflammatory properties while simultaneously avoiding the limitations of traditional antibiotic-loaded devices.
KW - Electrospinning
KW - Essential oils
KW - Inflammation
KW - Polycaprolactone
KW - Thymol
KW - Wound healing
KW - Cell Line
KW - Oils, Volatile/administration & dosage
KW - Wound Healing/drug effects
KW - Polyesters/chemistry
KW - Macrophages/drug effects
KW - Animals
KW - Anti-Inflammatory Agents/administration & dosage
KW - Inflammation/drug therapy
KW - Mice
KW - Nanofibers
UR - http://www.scopus.com/inward/record.url?scp=85078278542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078278542&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2020.119067
DO - 10.1016/j.ijpharm.2020.119067
M3 - Article
C2 - 31981705
AN - SCOPUS:85078278542
SN - 0378-5173
VL - 577
SP - 119067
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
M1 - 119067
ER -